Patent · US Active

Use of substituted quinazoline compounds in treating age-related macular degeneration

US8497372B2 · kind B2 · utility

0Cited by

3References

10Claims

0Family size

Assignee

Hutchison MediPharma Enterprises Limited · BS

Inventors

Wei-Guo Su · Shanghai, CN
Weihan Zhang · Shanghai, CN
Xiaoqiang Yan · Shanghai, CN
Yumin Cui · Shanghai, CN
Yongxin Ren · Shanghai, CN
Jifeng Duan · Shanghai, CN

Key dates

Filing date	Jun 4, 2012
Grant date	Jul 30, 2013
Priority date	—
Expiry date	Jun 4, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Quinazoline derivatives of the following formula:wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, and Z are defined herein. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.